KSQ Therapeutics
PrivateLast Round
Series C
Sep 28, 2018
Total Funding Raised
$156M
Company Overview
KSQ Therapeutics is a clinical-stage biotechnology company that utilizes its proprietary CRISPRomics® discovery engine to identify novel drug targets and develop treatments for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KSQ Therapeutics Comparables
Compare KSQ Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tango Therapeutics | 81% | |
| Maze Therapeutics | 80% | |
| Repare Therapeutics | 77% | |
KSQ Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 28, 2018 | ||||
| Series B | Oct 2, 2017 | ||||
| Seed | Oct 1, 2015 |
Key People
Founding team and executive leadership
KSQ Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cowen Private Investments | Series C |
| ARCH Venture Partners | Series B, Series C |
| Blue Owl Capital | Series C |
| Invus Opportunities | Series C |
| ARCH Venture Partners | Series B, Series C |
| Alexandria Venture Investments | Series B, Series C |
| Lilly Asia Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2025
Kristen Hege, M.D. appointed to the Board of Directors.
KSQ Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KSQ Therapeutics's valuation, stock price, and market status.